EBR Systems (ASX:EBR) announces the US FDA has accepted its final premarket approval application for the WiSE CRT System.

Pfizer withdraws OXBRYTA after post marketing studies showed that the risks of side effects were greater than the benefits.

The withdrawal comes after postmarketing studies showed that the risks of side effects were greater than the benefits.

The Ministry of Food and Drug Safety approved Novavax's vaccine for emergency use today (30th) in response to the "COVID-19 ...

ASX could hit record high despite mixed bag on Wall Street. US stocks expected to outperform bonds as Fed cuts rates.

PRNewswire Bengaluru Karnataka [India] September 30 Healthium Medtech a global player in medical devices focused on products ...

Ricoh USA, Inc. and Kallisio have announced a strategic collaboration to bring Stentra™, an innovative 510(k)-cleared oral ...

The fact that hearing loss doesn’t happen suddenly might be considered the cruelest part of having to wear hearing aids.

More than four years ago, former President Donald Trump’s administration accelerated the development and rollout of the covid ...

Caffeine augments fat burning and increases metabolic rate. The FDA has indicated consumption of 400mg of caffeine a day to ...

The Securities & Exchange Commission (SEC) has accused Cassava's founder and former chief executive Remi Barbier and former ...

If you’ve noticed the signs of male pattern baldness — say, a thinning hairline or a bald patch on the crown of your head — a ...